Analysts Set Ardent Health Partners, LLC (NYSE:ARDT) Price Target at $20.67

Ardent Health Partners, LLC (NYSE:ARDT) has received a consensus recommendation of “Buy” from the thirteen analysts that are covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation, nine have assigned a buy recommendation and two have assigned a strong buy recommendation to the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $20.67.

ARDT has been the topic of several analyst reports. Stephens restated an “overweight” rating and set a $21.00 price objective on shares of Ardent Health Partners in a report on Tuesday, May 20th. Royal Bank of Canada reissued an “outperform” rating and issued a $21.00 price target on shares of Ardent Health Partners in a research note on Thursday, May 15th. Guggenheim lifted their price target on Ardent Health Partners from $16.00 to $18.00 and gave the company a “buy” rating in a report on Friday, May 9th. Finally, Mizuho cut their price objective on shares of Ardent Health Partners from $19.00 to $18.00 and set an “outperform” rating on the stock in a report on Wednesday, April 9th.

Hedge Funds Weigh In On Ardent Health Partners

Several large investors have recently bought and sold shares of the stock. Point72 Asia Singapore Pte. Ltd. acquired a new stake in Ardent Health Partners during the fourth quarter worth $27,000. US Bancorp DE bought a new position in shares of Ardent Health Partners during the 4th quarter worth about $31,000. Morse Asset Management Inc acquired a new stake in shares of Ardent Health Partners during the 1st quarter valued at about $36,000. New York State Common Retirement Fund bought a new stake in Ardent Health Partners in the fourth quarter valued at about $48,000. Finally, Deutsche Bank AG increased its stake in Ardent Health Partners by 1,251.9% in the fourth quarter. Deutsche Bank AG now owns 2,866 shares of the company’s stock valued at $49,000 after acquiring an additional 2,654 shares during the period.

Ardent Health Partners Stock Performance

NYSE:ARDT opened at $13.37 on Friday. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. The firm has a market cap of $1.91 billion and a price-to-earnings ratio of 8.20. The firm’s fifty day moving average price is $13.52 and its 200 day moving average price is $14.55. Ardent Health Partners has a 1-year low of $11.31 and a 1-year high of $20.72.

Ardent Health Partners (NYSE:ARDT) last posted its quarterly earnings results on Tuesday, May 6th. The company reported $0.29 earnings per share for the quarter, topping analysts’ consensus estimates of $0.21 by $0.08. The company had revenue of $1.50 billion for the quarter, compared to analyst estimates of $1.50 billion. On average, sell-side analysts expect that Ardent Health Partners will post 1.23 EPS for the current year.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.